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Table 1. Diagnostic and clinical features of the four affected siblings 
 Sibling 1 Sibling 2 Sibling 3 Sibling 4 
 
Karyotype 
 
              46XX 
 
46XX 
 
46XY 
 
46XX 
 
Guthrie TSH (mU/L) 
 
213 
 
- 
 
188 
 
- 
 
Venous TSH on recall 
(mU/L) 
 
310.2 
 
- 
 
248.3 
 
- 
 
Venous FT4 on recall 
(pmol/L) 
 
<8 
 
- 
 
17.6 
 
- 
 
Basal 17-OHP at 
diagnosis (nmol/L) 
 
276 
 
10.1 
 
302 
 
49 
 
Peak of 17-OHP 30 
min post-Synacthen 
(nmol/L) 
 
- 
 
         71.9 81.9 
 
- 
 
144 
 
Age at diagnosis of 
CAH 
 
Day 3 
 
15.5 yrs 
 
Day 3 
 
9.8 yrs 
Presenting feature of 
CAH 
Virilised genitalia 
(Prader 3) 
Asymptomatic Absent 
(positive 
elective 
screening) 
Pubarche, 
increased 
growth rate,  
advanced bone 
age 
Complications during 
follow-up 
Precocious puberty 
Short stature 
Polycystic ovarian 
disease 
Right adrenal 
adenoma 
 
           - 
Precocious 
puberty 
Short stature 
 
 
           - 
 
Additional features 
 
Learning difficulties 
 
- 
 
Developmental 
delay 
 
- 
 
Clinical form of CAH 
 
Salt-wasting 
 
Non-classical 
(cryptic) 
 
Salt-wasting 
 
Non-classical 
 
